Showing results (51-60 of 511) with videos related to
Sort By:
Pageof 52
Cardiovascular Drugs and Therapy|October 1, 1989
Should the costs of development inhibit research into new antihypertensive drugs?J I RobertsonClinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
Hypertension and its treatment in the elderlyJ I RobertsonCardiovascular Drugs and Therapy|September 22, 2000
Which antihypertensive drug classes have been shown to be beneficial? What are their benefits? A critique of hypertension treatment trialsJ I RobertsonEuropean Heart Journal|March 1, 1984
Diuretics, potassium depletion and the risk of arrhythmiasJ I RobertsonJournal of Cardiovascular Pharmacology|January 1, 1991
Serotonergic type-2 (5-HT2) antagonists: a novel class of cardiovascular drugsJ I RobertsonJournal of Cardiovascular Pharmacology|January 1, 1986
Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failureJ I RobertsonJournal of Cardiovascular Pharmacology|January 1, 1987
Factors influencing treatment of hypertensionJ I RobertsonJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1990
Comparative studies in hypertension: some fallacious claims of age-related drug efficacyJ I RobertsonAustralian and New Zealand Journal of Medicine|February 1, 1990
Complications and causes of death in B cell chronic lymphocytic leukaemia: a long term study of 105 patientsT I RobertsonPageof 52